[
  {
    "ts": null,
    "headline": "Invesco American Franchise Fund Q3 2024 Commentary",
    "summary": "Invesco American Franchise Fund currently favors a balance of high quality companies with resilient growth and early cyclical companies with potential to benefit from lower interest rates.",
    "url": "https://finnhub.io/api/news?id=a0a53752da817cd91eeb9a3adcc1d8ca9f7f56ea34d728cc416e1dafc74310d6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732657020,
      "headline": "Invesco American Franchise Fund Q3 2024 Commentary",
      "id": 131655629,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/682049968/image_682049968.jpg?io=getty-c-w1536",
      "related": "EW",
      "source": "SeekingAlpha",
      "summary": "Invesco American Franchise Fund currently favors a balance of high quality companies with resilient growth and early cyclical companies with potential to benefit from lower interest rates.",
      "url": "https://finnhub.io/api/news?id=a0a53752da817cd91eeb9a3adcc1d8ca9f7f56ea34d728cc416e1dafc74310d6"
    }
  },
  {
    "ts": null,
    "headline": "Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)",
    "summary": "Key Insights Edwards Lifesciences' estimated fair value is US$69.12 based on 2 Stage Free Cash Flow to Equity Edwards...",
    "url": "https://finnhub.io/api/news?id=75725ac598514e1d2578b8f80bec77a4e3d34de221636fa9f4901cc8eef1b245",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732626012,
      "headline": "Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)",
      "id": 131654127,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Key Insights Edwards Lifesciences' estimated fair value is US$69.12 based on 2 Stage Free Cash Flow to Equity Edwards...",
      "url": "https://finnhub.io/api/news?id=75725ac598514e1d2578b8f80bec77a4e3d34de221636fa9f4901cc8eef1b245"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Health Care Fund Q3 2024 Commentary",
    "summary": "Invesco Health Care Fund underperformed its benchmark. Despite earlier signs of improving trends, our health care outlook is bearish. Read more here.",
    "url": "https://finnhub.io/api/news?id=8811a159dd6bae05dcf408a9f48cd5d03a26ef619260c992cad970093f4bc185",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732624620,
      "headline": "Invesco Health Care Fund Q3 2024 Commentary",
      "id": 131646502,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/183355336/image_183355336.jpg?io=getty-c-w1536",
      "related": "EW",
      "source": "SeekingAlpha",
      "summary": "Invesco Health Care Fund underperformed its benchmark. Despite earlier signs of improving trends, our health care outlook is bearish. Read more here.",
      "url": "https://finnhub.io/api/news?id=8811a159dd6bae05dcf408a9f48cd5d03a26ef619260c992cad970093f4bc185"
    }
  },
  {
    "ts": null,
    "headline": "Edwards SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data",
    "summary": "LONDON - Edwards Lifesciences today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve.The data were presented at PCR London Valves 2024...",
    "url": "https://finnhub.io/api/news?id=d5cd79536abf2b1726c61c6e3c44efb0e26007f752dfb77d45c866a902b10e8c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732615351,
      "headline": "Edwards SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data",
      "id": 131637061,
      "image": "",
      "related": "EW",
      "source": "Finnhub",
      "summary": "LONDON - Edwards Lifesciences today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve.The data were presented at PCR London Valves 2024...",
      "url": "https://finnhub.io/api/news?id=d5cd79536abf2b1726c61c6e3c44efb0e26007f752dfb77d45c866a902b10e8c"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Global Focus Fund Q3 2024 Commentary",
    "summary": "Class A shares underperformed the MSCI All-Country World Growth Index and the Morningstar Global Large Stock Growth Category average (5.10% return) during the third quarter.",
    "url": "https://finnhub.io/api/news?id=7d2da949f895b7f4ef7e25fbf9825772979aed3705277958d038f6859678db0d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732610400,
      "headline": "Invesco Global Focus Fund Q3 2024 Commentary",
      "id": 131633487,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1341631834/image_1341631834.jpg?io=getty-c-w1536",
      "related": "EW",
      "source": "SeekingAlpha",
      "summary": "Class A shares underperformed the MSCI All-Country World Growth Index and the Morningstar Global Large Stock Growth Category average (5.10% return) during the third quarter.",
      "url": "https://finnhub.io/api/news?id=7d2da949f895b7f4ef7e25fbf9825772979aed3705277958d038f6859678db0d"
    }
  },
  {
    "ts": null,
    "headline": "Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky",
    "summary": "NEW YORK, Nov. 26, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation of a class action securities lawsuit. ...",
    "url": "https://finnhub.io/api/news?id=426903b51b85508ce70baf81fa5414f8e29f5110b94e95a527a2c92f09c29cfc",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732597273,
      "headline": "Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky",
      "id": 131630266,
      "image": "",
      "related": "EW",
      "source": "Finnhub",
      "summary": "NEW YORK, Nov. 26, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation of a class action securities lawsuit. ...",
      "url": "https://finnhub.io/api/news?id=426903b51b85508ce70baf81fa5414f8e29f5110b94e95a527a2c92f09c29cfc"
    }
  }
]